Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 4–4 | Cite as

Adalimumab: no new safety signals in real-world setting

Clinical study
  • 17 Downloads

Reference

  1. Harrold LR, et al. Long-term, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-Based Registry. The Journal of Rheumatology : Aug 2019. Available from: URL: http://doi.org/10.3899/jrheum.190260

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations